Ultimovacs (OSE: ULTI)

Last close As at 20/12/2024

NOK7.55

0.06 (0.80%)

Market capitalisation

260m

Edison Investment Research is terminating coverage on Ultimovacs (ULTI). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Latest Insights

View More

Healthcare | Flash note

Ultimovacs — Steadfast commitment to UV1 progression

Healthcare | Flash note

Ultimovacs — UV1 hits transitory roadblock with INITIUM top-line

Healthcare | edison tv

Ultimovacs – executive interview

Ultimovacs_resized

Thematics

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free